Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Opt Soc Am A Opt Image Sci Vis ; 33(3): A283-99, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26974935

RESUMEN

We explored the color constancy mechanisms of color-deficient observers under red, green, blue, and yellow illuminations. The red and green illuminations were defined individually by the longer axis of the color discrimination ellipsoid measured by the Cambridge Colour Test. Four dichromats (3 protanopes and 1 deuteranope), two anomalous trichromats (2 deuteranomalous observers), and five color-normal observers were asked to complete the color constancy task by making a simultaneous paper match under asymmetrical illuminations in haploscopic view on a monitor. The von Kries adaptation model was applied to estimate the cone responses. The model fits showed that for all color-deficient observers under all illuminations, the adjustment of the S-cone response or blue-yellow chromatically opponent responses modeled with the simple assumption of cone deletion in a certain type (S-M, S-L or S-(L+M)) was consistent with the principle of the von Kries model. The degree of adaptation was similar to that of color-normal observers. The results indicate that the color constancy of color-deficient observers is mediated by the simplified blue-yellow color system with a von Kries-type adaptation effect, even in the case of brightness match, as well as by a possible cone-level adaptation to the S-cone when the illumination produces a strong S-cone stimulation, such as blue illumination.


Asunto(s)
Percepción de Color/efectos de la radiación , Defectos de la Visión Cromática/parasitología , Discriminación en Psicología/fisiología , Discriminación en Psicología/efectos de la radiación , Luz , Adulto , Defectos de la Visión Cromática/patología , Femenino , Humanos , Masculino , Modelos Biológicos , Estimulación Luminosa , Células Fotorreceptoras Retinianas Conos/patología , Células Fotorreceptoras Retinianas Conos/efectos de la radiación , Adulto Joven
2.
Hepatogastroenterology ; 62(139): 558-63, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-26897928

RESUMEN

BACKGROUND/AIMS: To clarify whether or not use of an endoscopic biliary stenting (EBS) is superior to endoscopic nasobiliary drainage (ENBD) in cases of acute cholangitis due to choledocholithiasis. METHODOLOGY: Of 447 patients with choledocholithiasis who were treated in the Department of Gastroenterology, Fukuoka University Chikushi Hospital between January 1994 and September 2006, the subjects were 99 moderate acute cholangitis patients who underwent endoscopic drainage as initial treatment. Clinical efficacy, complications and patient satisfaction (meal intake rete) were investigated in the EBS group (67 patients) and the ENBD group (32 patients). RESULTS: There were no significant differences in the improvement in inflammation, total bilirubin, or biliary enzymes between the EBS and ENBD groups. Catheter occlusion was seen in three patients (4%) in the EBS group, and the catheter was self-extracted by three patients (10%) in the ENBD group. CONCLUSION: In moderate acute cholangitis due to choledocholithisis, the treatment efficacy and safety of EBS are equal to those of ENBD, and EBS appears to be a better choice in elderly patients in particular.


Asunto(s)
Colangiopancreatografia Retrógrada Endoscópica/instrumentación , Colangitis/cirugía , Coledocolitiasis/cirugía , Descompresión Quirúrgica/instrumentación , Drenaje/instrumentación , Stents , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Colangitis/diagnóstico , Colangitis/etiología , Coledocolitiasis/complicaciones , Coledocolitiasis/diagnóstico , Descompresión Quirúrgica/efectos adversos , Descompresión Quirúrgica/métodos , Drenaje/efectos adversos , Drenaje/métodos , Femenino , Hospitales Universitarios , Humanos , Japón , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento
3.
Pancreas ; 44(3): 434-40, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25469544

RESUMEN

OBJECTIVES: The purpose of this study was to clarify the clinicopathological characteristics of autoimmune pancreatitis (AIP) in Japanese patients with inflammatory bowel disease (IBD). METHODS: The clinicopathological findings of 7 patients with IBD whose definite AIP was diagnosed in our hospital according to the International Consensus Diagnostic Criteria were reviewed. RESULTS: Five (0.5%) of 961 patients with ulcerative colitis (UC) and 2 (0.3%) of 790 patients with Crohn disease had AIP. All of 7 patients whose AIP was diagnosed were type 2. The rate of elevated values of serum immunoglobulin G4 was 0%. Most patients with the diagnosis of IBD preceded that of AIP, and disease activity of IBD were active. Granulocyte epithelial lesion is similar to the cryptitis seen in colonic tissue of UC. All of 7 patients were given corticosteroids, immunomodulators, and/or biological agents for IBD. One patient had a recurrence. CONCLUSIONS: The frequency of AIP in Japanese patients with IBD was low. All cases were type 2 and responded well to corticosteroids, immunomodulators, and biological agents. Autoimmune pancreatitis in UC patients may be an extraintestinal manifestation of UC.


Asunto(s)
Enfermedades Autoinmunes/etnología , Colitis Ulcerosa/etnología , Enfermedad de Crohn/etnología , Pancreatitis/etnología , Adolescente , Corticoesteroides/uso terapéutico , Adulto , Anciano , Enfermedades Autoinmunes/diagnóstico , Enfermedades Autoinmunes/tratamiento farmacológico , Enfermedades Autoinmunes/inmunología , Productos Biológicos/uso terapéutico , Biomarcadores/sangre , Biopsia , Colangiopancreatografia Retrógrada Endoscópica , Colitis Ulcerosa/diagnóstico , Colitis Ulcerosa/tratamiento farmacológico , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/diagnóstico , Enfermedad de Crohn/tratamiento farmacológico , Enfermedad de Crohn/inmunología , Bases de Datos Factuales , Femenino , Humanos , Inmunoglobulina G/sangre , Factores Inmunológicos/uso terapéutico , Incidencia , Japón/epidemiología , Masculino , Pancreatitis/diagnóstico , Pancreatitis/tratamiento farmacológico , Pancreatitis/inmunología , Prevalencia , Estudios Retrospectivos , Tomografía Computarizada por Rayos X , Adulto Joven
4.
Jpn J Ophthalmol ; 58(4): 381-7, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-24871639

RESUMEN

PURPOSE: To evaluate the repeatability of a new method of measurement of visual acuity by use of a psychometric function. METHODS: The visual acuity of 15 healthy adults was measured by use of a psychometric function (PFVA) and by use of a conventional method using a decimal visual acuity chart (DeVA). We performed two tests. To evaluate intra-rater reliability, a tester measured the visual acuity three times for each subject, and the intraclass correlation coefficients, ICC (1,1), were calculated for PFVA and DeVA. Next, to evaluate inter-rater reliability, three testers measured the visual acuity for one subject, and the ICC (2,1) were calculated for PFVA and DeVA. The PFVA and DeVA of five subjects with ocular diseases were also measured. RESULTS: In the evaluation of intra-rater reliability, the ICC (1,1) of the DeVA was 0.83 and the ICC (1,1) of the PFVA was 0.95. In the evaluation of inter-rater reliability, the ICC (2,1) of the DeVA was 0.88 and the ICC (2,1) of the PFVA was 0.93. In both tests the standard deviations of the PFVA were significantly lower than those of the DeVA. For four of the five subjects with ocular diseases, the PFVA was significantly improved by treatment. CONCLUSION: The repeatability of our method is better than that of the conventional method using a decimal visual acuity chart.


Asunto(s)
Psicometría , Pruebas de Visión/métodos , Agudeza Visual/fisiología , Anciano , Catarata/fisiopatología , Oftalmopatías/fisiopatología , Femenino , Voluntarios Sanos , Humanos , Edema Macular/fisiopatología , Masculino , Persona de Mediana Edad , Variaciones Dependientes del Observador , Reproducibilidad de los Resultados , Pruebas de Visión/instrumentación , Cuerpo Vítreo/patología , Adulto Joven
5.
Jpn J Ophthalmol ; 55(3): 175-182, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21538004

RESUMEN

PURPOSE: A three-dimensional (3D) image viewing experiment was performed using a new 3D scenography system. The influence on visual function was investigated both in adults and in children employing both objective and subjective methods. METHODS: The subjects were 21 healthy adults (mean age ± standard deviation: 42.1 ± 10.0 years) and 21 healthy children (7.8 ± 1.5 years). The 3D image viewing time was set at 90 min for adults and 60 min for children, and the visual function was objectively evaluated using an accommodative microfluctuation analysis system both before and after 3D image viewing. In addition, subjective symptoms were surveyed employing a questionnaire both before and after viewing in the adult group to subjectively evaluate the visual function. RESULTS: No significant difference was noted in accommodative microfluctuation between the before and after viewing in either the adult or child group, nor was there a significant difference in subjective symptoms in the adult group based on the questionnaire. However, accommodative microfluctuation tended to increase after viewing in some subjects. CONCLUSIONS: Under the conditions of this study, 3D image viewing did not influence visual function, or only very slightly influenced it, if at all, but there are many unknown problems, requiring further surveys using 3D image viewing.


Asunto(s)
Acomodación Ocular/fisiología , Imagenología Tridimensional , Refracción Ocular/fisiología , Percepción Visual/fisiología , Adulto , Niño , Preescolar , Femenino , Humanos , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios
6.
Histopathology ; 55(6): 641-53, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20002766

RESUMEN

AIMS: To investigate the clinicopathological characteristics of 20 primary gastric T-cell lymphoma (GTCL) cases without human T-lymphotropic virus type I infection in Japan, a non-endemic area for coeliac disease. METHODS AND RESULTS: Fifteen cases had no history of persistent diarrhoea or severe hypoproteinaemia. Histologically, 13 cases (65%) consisted of large cell lymphoma and seven (35%) were of medium-sized cells. Intraepithelial lymphoma cell invasion was found in three cases (15%). Two of 10 surgical cases (20%) showed intramucosal tumour cell spreading with enteropathy-like features. Helicobacter pylori CagA gene was detected in three of 10 cases (30%). The lymphoma cells of all 20 cases were positive for CD3 and/or TCRbetaF1 and negative for CD56. CD4- and CD8- lymphoma was found in 11 cases (55%), CD4+ lymphoma in seven (35%) and CD8+ lymphoma in two (10%). CD30+, CD5+ and CD25+ lymphomas were detected in nine (45%), 10 (50%) and 11 (55%) cases, respectively. Five-year survival of the 16 available cases was 54%. Early clinical stage and medium-sized cell lymphoma were significantly (P < 0.05) better prognostic factors. CONCLUSIONS: Patients with GTCL exhibit distinct clinicopathological findings and prognoses from those with enteropathy-associated T-cell lymphomas. GTCL may be mainly derived from lamina propria and parafollicular T cells.


Asunto(s)
Linfoma de Células T Periférico/patología , Neoplasias Gástricas/patología , Estómago/patología , Adulto , Anciano , Anciano de 80 o más Años , Antígenos CD/metabolismo , Femenino , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patología , Genes Codificadores de la Cadena gamma de los Receptores de Linfocito T/fisiología , Infecciones por Helicobacter/patología , Helicobacter pylori/aislamiento & purificación , Humanos , Inmunohistoquímica , Inmunofenotipificación , Hibridación in Situ , Linfoma de Células T Periférico/metabolismo , Linfoma de Células T Periférico/microbiología , Masculino , Persona de Mediana Edad , Pronóstico , Proteínas de Unión al ARN/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteínas Ribosómicas/metabolismo , Estómago/microbiología , Neoplasias Gástricas/metabolismo , Neoplasias Gástricas/microbiología , Linfocitos T/patología
7.
J Gastroenterol ; 44(10): 1080-8, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19597758

RESUMEN

PURPOSE: We retrospectively assessed post-EST complications and examined whether combination therapy comprising endoscopic biliary drainage (EBD) plus endoscopic sphincterotomy (EST) as the initial treatment is safe in patients with acute cholangitis due to choledocholithiasis. METHODS: Among the 363 consecutive patients with acute cholangitis due to choledocholithiasis who were treated in our hospital between December 1992 and December 2006, the subjects comprised 127 patients with moderate acute cholangitis for whom EBD and EST were carried out. Factors influencing risk factors for post-EST pancreatitis, hemorrhage and hospitalization were determined by multivariate analysis. RESULTS: Multivariate analysis revealed that only precut sphincterotomy (PST) was a significant risk factor for post-EST pancreatitis, and the incidence of pancreatitis in patients who underwent PST was significantly higher than that in those who did not (P = 0.041). Only age was a significant risk factor for post-EST hemorrhage, and younger patients were likely to experience hemorrhage after EST (P = 0.021). Total bilirubin and the timing of EST were significant factors associated with hospitalization. Hospitalization in patients who underwent EBD plus EST as the initial treatment (emergency EST) was significantly shorter than that in those who palliatively underwent EST after EBD (elective EST; 11.8 vs. 16.2 days, P = 0.001). CONCLUSIONS: Combination therapy comprising EBD plus EST as the initial treatment for patients with moderate acute cholangitis due to choledocholithiasis was safe and did not prolong the period of hospitalization.


Asunto(s)
Colangitis/etiología , Colangitis/terapia , Coledocolitiasis/complicaciones , Drenaje , Esfinterotomía Endoscópica , Enfermedad Aguda , Factores de Edad , Anciano , Colangiopancreatografia Retrógrada Endoscópica , Terapia Combinada , Drenaje/efectos adversos , Procedimientos Quirúrgicos Electivos , Urgencias Médicas , Femenino , Hemorragia Gastrointestinal/epidemiología , Hemorragia Gastrointestinal/etiología , Hospitalización , Humanos , Tiempo de Internación , Masculino , Análisis Multivariante , Pancreatitis/epidemiología , Pancreatitis/etiología , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Factores de Riesgo , Esfinterotomía Endoscópica/efectos adversos , Resultado del Tratamiento
8.
J Gastroenterol ; 42(2): 161-7, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-17351806

RESUMEN

BACKGROUND: It has been reported that the administration of ulinastatin, gabexate mesylate, or somatostatin may be effective in the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. However, few randomized trials of ulinastatin and gabexate mesylate for the prevention of post-ERCP pancreatitis have been reported. The aim of this study was to compare the efficacy of ulinastatin and gabexate mesylate for the prevention of post-ERCP pancreatitis. METHODS: Sixty-eight patients who underwent diagnostic ERCP at our hospital were divided at random by computer-generated randomization into an ulinastatin group (n = 34) and a gabexate group (n = 34). Each patient received a continuous intravenous infusion of ulinastatin (150,000 units) or gabexate mesylate (600 mg), beginning 60-90 min before the ERCP and continuing until 22 h after the ERCP. The primary endpoint was the incidence of post-ERCP pancreatitis, and the secondary endpoints were the incidences of hyperenzymemia and pain. RESULTS: The overall incidence of post-ERCP pancreatitis was 2.9% (two patients), comprising one patient in the ulinastatin group and one patient in the gabexate group (2.9% vs 2.9%, respectively). Neither of these two patients developed severe pancreatitis. There were no significant differences in the serum levels of pancreatic enzymes or in the levels of pain between the two groups. CONCLUSIONS: There was no clinical difference between the effect of preventive administration of ulinastatin and that of gabexate mesylate on the incidence of post-ERCP pancreatitis. Ulinastatin may be equivalent in efficacy to gabexate for reducing the incidence of post-ERCP pancreatitis.


Asunto(s)
Colangiopancreatografia Retrógrada Endoscópica/efectos adversos , Gabexato/uso terapéutico , Glicoproteínas/uso terapéutico , Pancreatitis/etiología , Pancreatitis/prevención & control , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA